8-K - BIO-key International, Inc. | StockGist

AI Analysis

AI-generated analysis. Always verify with the original filing.

BIO-key International reported a 12% revenue decline to $6.1 million for 2025, with a net loss of $4.6 million, but highlighted a strong cash position increase and preliminary Q1 2026 revenue growth of 37%.

Key Takeaways

12025 revenue decreased 12% to $6.1M due to contract timing and EMEA transition, with license fees down 31%.

2Net loss widened to $4.6M ($0.69 per share) from $4.3M ($2.09 per share) in 2024 despite 7% lower operating expenses.

3Cash position improved to $2.7M at year-end 2025, up from $0.4M in 2024, strengthening financial flexibility.

4Preliminary Q1 2026 revenue of $2.2M represents 37% growth over Q1 2025 and 80% over Q4 2025.

5Company expects solid revenue growth and improved bottom line in 2026, targeting break-even results.

6Defense sector generated over $2.2M in revenue over the last twelve months, including recent $500k in orders.

Current Report Details

Event Type

Financial Results

Exhibits Only

Disclosure

Mandatory

Variant

8-K

Items Reported

2.02

.** **Results of Operations and Financial Condition.** On March 31,2026, BIO-key International, Inc. (the “Company”) issued a press release announcing its finan

Financial Results

9.01

.** **Financial Statements, Pro Forma Financial Information and Exhibit.** (d) Exhibits. The following exhibit is furnished herewith: | 99.1 | Press Release, da

Exhibits Only

Source Document

Results of Operations

Year ended December 31, 2025

Metric	Value	Prior Period
Revenue	$6.10	$6.93
Gross Profit	$4.72	$5.64
Gross Margin	77.5%	81.4%
Net Loss	$4.59	$4.30
Diluted EPS	$-0.69	$-2.09

Forward Guidance

Full Year 2026

Revenue

Solid revenue growth

Bottom Line

Improved bottom line

Exhibits (2)

8-K

FORM 8-K

99.1

EXHIBIT 99.1